Immunosuppressants - Angola

Angola

in Angola, an African country, is a part of the Immunosuppressants market.
The market is expected to witness significant growth in the coming years.
According to projections, the revenue in the Immunosuppressants market is expected to reach US$9.17m in 2024.
This revenue is anticipated to show a compound annual growth rate (CAGR) of 15.19% from 2024 to 2029, resulting in a market volume of US$18.60m by 2029.
When comparing the global market, United States is expected to generate the highest revenue in the Immunosuppressants market.
In 2024, the projected revenue for the United States is estimated to be US$35,470.00m.
This indicates the dominant position of the United States in terms of market size and potential in the Immunosuppressants market.
The immunosuppressants market in Angola is witnessing a surge in demand due to an increasing number of organ transplant surgeries in the country.

Key regions: Australia, Germany, United Kingdom, United States, France

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for immunosuppressants in Angola has been on the rise in recent years.

Customer preferences: The increase in demand for immunosuppressants in Angola can be attributed to the rise in chronic diseases, such as diabetes and hypertension, which require long-term treatment. Additionally, there has been an increase in the number of organ transplant surgeries in the country, which has also contributed to the growth of the immunosuppressants market.

Trends in the market: One of the trends in the immunosuppressants market in Angola is the shift towards the use of generic drugs. This is due to the high cost of branded drugs, which are often unaffordable for many patients. As a result, there has been an increase in the production and distribution of generic immunosuppressants in the country.

Local special circumstances: Angola has a high burden of communicable diseases, such as malaria and tuberculosis, which has led to a focus on improving the country's healthcare system. The government has been investing heavily in the healthcare sector, including the procurement of essential medicines, such as immunosuppressants. However, there are still challenges in the distribution of these medicines to remote areas of the country.

Underlying macroeconomic factors: The growth of the immunosuppressants market in Angola is also influenced by the country's economic situation. Angola is heavily dependent on its oil exports, and the decline in oil prices in recent years has led to a decrease in government revenue. This has had an impact on the healthcare sector, with some hospitals experiencing shortages of essential medicines. However, the government has continued to prioritize healthcare spending, which has helped to mitigate some of the challenges in the sector.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.